This page shows the latest healthcare reforms news and features for those working in and with pharma, biotech and healthcare.
Nevertheless, there remains much uncertainty about Trump's exact position on the industry and healthcare in general. ... In contrast Trump's plan is to repeal the Act and “bring much-needed free market reforms to the healthcare industry”.
Chief among these were US healthcare reforms, the severe spending cuts that followed and consolidation within the US insurance industry, but the pressure appears to have eased considerably in 2015.
However, in the US, it wasn't until 2010 when Obama's healthcare reforms permitted the use of biosimilars - drugs that are bioequivalent versions of original medicines, but require some
In 2010, President Barack Obama's healthcare reforms allowed the use of biosimilars in the country - drugs that are bioequivalent to original medicines, but which require some R&D as they
US operations hit hard by healthcare reforms and insurance consolidation. . Boehringer Ingelheim's sales fell by 5.3% to 13.3bn last year, driven down by tough operating conditions in the ... US healthcare reforms, the severe spending cuts that
In 2010 US President Barack Obama introduced new healthcare reforms that allowed biosimilars onto the market, but it has proved a difficult path for the regulator, which had no reference points ... Express Scripts estimates that the US healthcare system
More from news
Approximately 2 fully matching, plus 59 partially matching documents found.
Why personalised medicine based on our own genomes is the future of healthcare. ... Most importantly, we have still been fortunate enough to witness medical and scientific breakthroughs, helping families marked by devastating diseases to find new hope
The Russian healthcare sector is still shaped by the legacy of the Soviet Union and the decade of economic turmoil that followed.While reforms introduced in the past two decades have ... The financing reforms coincided with a decade of economic
Primarily, change is needed in response to global healthcare reforms requiring companies to demonstrate how their products improve patient outcomes, lower costs or both. ... innovative thinkers at its helm, the healthcare industry will be better able to
Is the stage set for price controls in the US? Most stakeholders in the US healthcare marketplace would prefer to see the Affordable Care Act survive ongoing efforts at repeal and ... Even so, the idea of repeal and replace as an actual attempt to
In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers. ... Broad-based healthcare reforms, new pricing regulations, increasing tendering processes and emphasis on
More from intelligence
Approximately 1 fully matching, plus 17 partially matching documents found.
McCann Worldgroup is expanding these regional operations in response to changes in the consumer and healthcare communications environment, in part related to healthcare insurance reforms in the US. ... The expansion includes an extensive investment
In this role, he has handled directly the impact of President Obama's healthcare reforms, heading up the company's reform implementation and care innovation plans, which include developing new models ... This extensive career in healthcare was commended
They join a senior team headed by Dr Katherine Rake, who was appointed chief executive in December 2012, shortly after the body was formed as part of major reforms to the ... Both new appointments have experience across the UK healthcare industry, with
for BSkyB, and he will have a challenge on his hands to gain public support for his predecessor's much criticised healthcare reforms. ... Stephen Whitehead, CEO of the Association of the British Pharmaceutical Industry (ABPI), also commented on Hunt's
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Watch this webcast in which Research Partnership's emerging market experts explore the recent 2020 healthcare reforms, digital transformations as a result of COVID-19, and how pharma can play and
In this paper, experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch
That may all be set to change though. The country’s recent 2020 healthcare reforms aim to rapidly increase the pace of new drug approvals and fast track innovative treatments, opening ... 2. What's changed? The key opportunities under China's 2020
the Government's healthcare reforms on the patient journey and consider the possible implication for market researchers. ... Identify the opportunities and challenges associated with the healthcare reforms . Learn how to ensure that your market
Favorable Government Support. Since the 2003 Healthcare Transformation Program (HTP), Turkey has undergone radical healthcare reforms with the end goal of universal healthcare coverage. ... As healthcare reforms have increased patient access, so have
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...